Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding iTeos Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ITOS: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders771118+42
Shares31.2M32.0K33.4M+2.28M (+7.3%)
Value$841.3M$863.0K$1.55B+$713.1M (+84.8%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ITOS in Q4 2021
InstitutionSharesValue% of portfolio
Octagon Capital Advisors LP450,776$21.0M4.08%
Millennium Management LLC227,436$10.6M0.01%
Hillsdale Investment Management Inc.146,500$6.82M0.46%
Point72 Asset Management, L.P.105,030$4.89M0.02%
Federated Hermes, Inc.95,798$4.46M0.01%
ExodusPoint Capital Management, LP81,511$3.79M0.05%
Susquehanna International Group, LLP76,850$3.58M0.01%
EAM Investors, LLC65,707$3.06M0.50%
Prudential Financial Inc56,630$2.64M0.00%
Allspring Global Investments Holdings, LLC56,503$2.63M0.00%
Norges Bank52,500$2.44M0.00%
Integral Health Asset Management, LLC50,000$2.33M0.65%
American Century Companies Inc48,208$2.25M0.00%
Jacobs Levy Equity Management, Inc45,551$2.12M0.01%
EAM Global Investors LLC43,493$2.02M0.36%
Putnam Investments LLC42,309$1.97M0.00%
Jump Financial, LLC41,900$1.95M0.12%
Rafferty Asset Management, LLC40,316$1.88M0.01%
Jackson Creek Investment Advisors LLC37,994$1.77M0.63%
HighVista Strategies LLC34,487$1.61M1.28%
Walleye Capital LLC34,253$1.59M0.05%
Renaissance Technologies LLC33,100$1.54M0.00%
Swiss National Bank31,000$1.44M0.00%
Corton Capital Inc.27,377$1.27M0.57%
Massachusetts Financial Services Co24,829$1.16M0.00%
Vident Investment Advisory, LLC24,153$1.13M0.03%
First Republic Investment Management, Inc.23,617$1.10M0.00%
Cinctive Capital Management LP21,200$987.0K0.05%
Perceptive Advisors LLC20,000$931.0K0.01%
SEI Investments Co17,819$830.0K0.00%
Alberta Investment Management Corp16,777$781.0K0.00%
AlphaCentric Advisors LLC15,000$698.0K0.20%
Jane Street Group, LLC14,853$692.0K0.00%
Fifth Lane Capital, LP14,566$678.0K0.40%
Credit Suisse AG11,502$535.0K0.00%
Delphia (USA) Inc.10,631$495.0K0.53%
Acadian Asset Management LLC7,497$347.0K0.00%
Verition Fund Management LLC6,435$300.0K0.00%
Old Well Partners, LLC5,096$237.0K0.15%
Nomura Holdings Inc4,852$226.0K0.00%
Russell Investments Group, Ltd.4,400$204.0K0.00%
Lazard Asset Management LLC3,837$178.0K0.00%
Nisa Investment Advisors, LLC2,600$95.0K0.00%
Lindbrook Capital, LLC930$43.0K0.01%
Great West Life Assurance Co785$36.0K0.00%
Signaturefd, LLC5$00.00%

Sold out (4)

Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ITOS in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
683 Capital Management, LLC200,413$5.41M
Mirabella Financial Services LLP14,280$386.0K
Boothbay Fund Management, LLC9,888$267.0K
Penserra Capital Management LLC805$21.0K

Not filed for Q4 2021 yet (1)

Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ITOS in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.31,976$863.0K